TrialInternational journal of hematology2025

A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma.

Ikuyo Tsutsumi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.